175 related articles for article (PubMed ID: 33439304)
1. G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Youssef JG; Zahiruddin F; Youssef G; Padmanabhan S; Ensor J; Pingali SR; Zu Y; Sahay S; Iyer SP
Ann Hematol; 2021 Mar; 100(3):667-673. PubMed ID: 33439304
[TBL] [Abstract][Full Text] [Related]
2. Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
Onori ME; Ricciardi Tenore C; Urbani A; Minucci A
Mol Biol Rep; 2021 Mar; 48(3):2973-2978. PubMed ID: 33620659
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
7. Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience.
Mahida RY; Chotalia M; Alderman J; Patel C; Hayden A; Desai R; Beesley E; Crowley LE; Soltan M; Bangash M; Parekh D; Patel J; Thickett DR
BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33257441
[TBL] [Abstract][Full Text] [Related]
8. Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis.
Boglione L; Olivieri C; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Biffi S; Borrè S
Adv Med Sci; 2021 Sep; 66(2):262-268. PubMed ID: 34022675
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
Beauverd Y; Adam Y; Assouline B; Samii K
Eur J Haematol; 2020 Sep; 105(3):357-359. PubMed ID: 32324284
[TBL] [Abstract][Full Text] [Related]
10. Association of Glucose-6-Phosphate Dehydrogenase Deficiency With Outcomes in US Veterans With COVID-19.
Elsea SH; Razjouyan J; Lee KM; Lynch JA; Martini S; Pandit LM
JAMA Netw Open; 2023 Mar; 6(3):e235626. PubMed ID: 36988953
[TBL] [Abstract][Full Text] [Related]
11. Associations between COVID-19 and Glucose-6-Phosphate Dehydrogenase Activity in Brazil.
de Almeida Rodrigues MG; Monteiro WM; de Melo GC; Dias ÁLB; Sartim MA; Xavier MS; Netto RLA; Almeida FF; Baía-da-Silva DC; Brito-Sousa JD; de Lacerda MVG; de Souza Sampaio V
Am J Trop Med Hyg; 2024 Jun; 110(6):1191-1197. PubMed ID: 38593787
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
Kheng S; Muth S; Taylor WR; Tops N; Kosal K; Sothea K; Souy P; Kim S; Char CM; Vanna C; Ly P; Ringwald P; Khieu V; Kerleguer A; Tor P; Baird JK; Bjorge S; Menard D; Christophel E
BMC Med; 2015 Aug; 13():203. PubMed ID: 26303162
[TBL] [Abstract][Full Text] [Related]
13. Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.
Dziewulska KH; Reisz JA; Hay AM; D'Alessandro A; Zimring JC
J Pharmacol Exp Ther; 2023 Sep; 386(3):323-330. PubMed ID: 37348965
[TBL] [Abstract][Full Text] [Related]
14. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
[TBL] [Abstract][Full Text] [Related]
15. A positive correlation between sickle cell anemia and g6pd deficiency from population of Chhattisgarh, India.
Shivwanshi LR; Singh E; Kumar A
Gene; 2019 Jul; 707():143-150. PubMed ID: 31075411
[TBL] [Abstract][Full Text] [Related]
16. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
17. NEUROPROTECTIVE AND ANTIOXIDANT POTENTIAL OF MONTELUKAST-ACETYLCYSTEINE COMBINATION THERAPY FOR BRAIN PROTECTION IN PATIENTS WITH COVID-19 INDUCED PNEUMONIA.
Samsonia M; Kandelaki M; Baratashvili N; Gvaramia L
Georgian Med News; 2023 Feb; (335):111-118. PubMed ID: 37042600
[TBL] [Abstract][Full Text] [Related]
18. Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.
Tsegaye A; Golassa L; Mamo H; Erko B
Malar J; 2014 Nov; 13():438. PubMed ID: 25406667
[TBL] [Abstract][Full Text] [Related]
19. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.
Taher A; Lashgari M; Sedighi L; Rahimi-Bashar F; Poorolajal J; Mehrpooya M
Pharmacol Rep; 2021 Dec; 73(6):1650-1659. PubMed ID: 34114174
[TBL] [Abstract][Full Text] [Related]
20. Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients.
Hultström M; Hellkvist O; Covaciu L; Fredén F; Frithiof R; Lipcsey M; Perchiazzi G; Pellegrini M
Crit Care; 2022 Mar; 26(1):55. PubMed ID: 35255949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
